$VBIO - New interim CEO credentials: Dean Zikria, a current member of the Board, has been appointed Interim Chief Executive Officer ("CEO"). In this role, Mr.

$VBIO - New interim CEO credentials: Dean Zikria, a current member of the Board, has been appointed Interim Chief Executive Officer ("CEO"). In this role, Mr. Zikria will oversee Valion's strategic priorities, including accelerating the clinical advancement of Entolimod and aggressively pursuing c…